On June 19 and 20, world-leading neuromuscular experts participated in two virtual symposia at the 7th Annual Meeting of the European Academy of Neurology. Here’s a recap of the event:
The characters shown are real patients and the required consent to use their stories has been obtained from the patients and families. Photographs are for illustrative purposes only.
Share page
ADULTS WITH SMA
Over the course of two connected symposia, neuromuscular experts discussed the latest SMA evidence and shared their perspectives on what this means for treating adults with SMA.
Using real-life cases studies of adult patients with SMA, Dr. Konersman and Dr. Kostera-Pruszczyk examined the challenges of treatment access and outcome expectations.
Symposium 2: How to define the treatment response
In the second symposium, the doctors considered approaches in defining response to treatment for adults with SMA, reviewing two case studies from their respective clinics.
Meet the faculty
Chamindra Konersman
MD
University of California San Diego (UCSD) and Rody Children’s Hospital, San Diego, CA, USA
Anna Kostera-Pruszczyk
MD, PhD
Central Clinical Hospital University Clinical Center of the Medical University of Warsaw, Warsaw, Poland
More Resources about SMA for Healthcare Professionals
Stabilisation of motor function is an important goal for adults living with SMA.1 Learn more about the differences in treatment goals between adults and children living with SMA.
Now that supportive care is improving, care expectations are even greater. Explore Biogen’s website to learn how discussing new care options with your patients can make a difference.
1. 1. Rouault F, et al. Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients. Neuromuscul Disord 2017;27(5):428-438.
